Telmisartan 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FJLGC
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,678
Award facts
- Contract value 100% obligated
- $1,678.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,678.00 to DMS Pharmaceutical Group Inc. on September 17, 2025, for the supply of Telmisartan 40 mg tablets (30-count units). This firm fixed-price delivery order, which must be completed by September 18, 2025, was issued without a set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge location. The company specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to federal agencies, with a particular focus on supporting Department of Defense healthcare facilities.
This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the DLA under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. The parent IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across military health facilities nationwide and worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain through consistent performance on delivery orders covering an extensive portfolio of medications and medical products.
Quick answers
Who was awarded contract SPE2DB25FJLGC?
SPE2DB25FJLGC was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FJLGC worth?
The government has obligated $1,678 on SPE2DB25FJLGC.
Is contract SPE2DB25FJLGC an order under another contract?
Yes. SPE2DB25FJLGC is a delivery order under SPE2DB24D9802, an indefinite delivery contract.
Was contract SPE2DB25FJLGC competed?
The extent of competition for SPE2DB25FJLGC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award